(Q38074079)

28 August 2017

1 reference

title

Active surveillance for prostate cancer: overview and update (English)

1 reference

28 August 2017

1 reference

1

Laurence Klotz

1 reference

28 August 2017

publication date

1 March 2013

1 reference

Current Treatment Options in Oncology

28 August 2017

published in

1 reference

28 August 2017

volume

14

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

97-108

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-012-0221-5

28 August 2017

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

21 January 2018

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Comorbidity and mortality results from a randomized prostate cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Rethinking screening for breast cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Cancer overdiagnosis and overtreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Early outcomes of active surveillance for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Active surveillance for the management of prostate cancer in a contemporary cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Outcomes of active surveillance for men with intermediate-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Effect of dutasteride on the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Radical prostatectomy versus watchful waiting in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0221-5

Early prostate cancer--treat or watch?

21 January 2018

1 reference

12 December 2020

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

1 reference

12 December 2020

A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer

1 reference

12 December 2020

Expectant management with selective delayed intervention for favorable risk prostate cancer

1 reference

12 December 2020

Should we really consider Gleason 6 prostate cancer?

1 reference

12 December 2020

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

1 reference

12 December 2020

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

12 December 2020

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

1 reference

12 December 2020

Comparing prostate specific antigen triggers for intervention in men with stable prostate cancer on active surveillance

1 reference

12 December 2020

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer

1 reference

12 December 2020

Modified Gleason grading. An updated review

1 reference

12 December 2020

Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics

1 reference

12 December 2020

10.1007/S11864-012-0221-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1045018284

0 references

1 reference